Display Settings:

Format

Send to:

Choose Destination
    Minerva Ginecol. 2008 Feb;60(1):77-82.

    Role of metformin in patients with polycystic ovary syndrome: the state of the art.

    Source

    Department of Gynecology and Obstetrics, Magna Graecia University of Catanzaro, Catanzaro, Italy. stefanopalomba@tin.it

    Abstract

    Metformin, an insulin sensitizer widely used for the treatment of patients with type-2 diabetes mellitus (DM), was recently introduced in the clinical practice to treat women with polycystic ovary syndrome (PCOS). The aim of the current review was to evaluate the current role of metformin in the treatment of the PCOS-related disorders. The Authors analyze here the administration of metformin for treating the ovarian dysfunction due to PCOS, and show the evidences available in literature regarding its alternative uses.

    PMID:
    18277354
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk